Onderneming Arca Biopharma Inc Nasdaq
Aandelen
US00211Y2090
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01-10-06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10-05-21 |
Sharon Perry
LAW | General Counsel | - | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16-02-17 |
Robert Conway
CHM | Chairman | 70 | 03-09-13 |
Linda Grais
BRD | Director/Board Member | 68 | 01-05-07 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 15-06-22 |
James Flynn
BRD | Director/Board Member | 43 | 15-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 507 143 | 14 320 024 ( 98,71 %) | 0 | 98,71 % |
Bedrijfsgegevens
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+0,09% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-8,07% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |